GLUT-1 Expression in Proliferative Endometrium, Endometrial Hyperplasia, Endometrial Adenocarcinoma and the Relationship Between GLUT-1 Expression and Prognostic Parameters in Endometrial Adenocarcinoma

被引:6
|
作者
Canpolat, Tuba [1 ]
Ersoz, Canan [1 ]
Uguz, Aysun [1 ]
Vardar, Mehmet Ali [2 ]
Altintas, Aytekin [2 ]
机构
[1] Cukurova Univ, Sch Med, Dept Pathol, Adana, Turkey
[2] Cukurova Univ, Sch Med, Dept Obstet & Gynecol, Adana, Turkey
关键词
GLUT-1; Prognosis; Endometrial hyperplasia; Endometrioid adenocarcinoma;
D O I
10.5146/tjpath.2015.01352
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objective: Malignant cells show increased glucose uptake in in vitro and in vivo studies. This uptake is mediated by glucose transporter proteins. GLUT-1 is the most common transporter protein, and its expression is reported to be increase in many human cancers. The aim of this study is to determine the GLUT-1 overexpression in benign, hyperplastic, and malignant endometrial tissues, to evaluate the usefulness of GLUT-1 expression in endometrial hyperplasia, and to determine its role in the neoplastic progression to endometrioid type adenocarcinoma. We also aimed to analyze prognostic clinical parameters, predict prognosis, and survival. Material and Method: We examined immunohistochemical expression of GLUT-1 in 91 cases of endometrial hyperplasia, 100 cases of endometrioid type adenocarcinoma, and 10 proliferative endometrial tissues. The percentage of positive cells and staining intensity were assessed in a semi quantitative fashion and scored (1+ to 3+). Results: GLUT-1 immunoreactivity was not present in proliferative endometrium. Twenty-nine (31.9%) of 91 endometrial hyperplasia cases showed positive immunoreactivity, of which only six were cases of hyperplasia without atypia while 23 of them were cases with atypia. We found GLUT-1 positivity of 95% in endometrioid type adenocarcinoma. GLUT-1 overexpression was not significantly correlated with any of the clinicopathological parameters except histological grade in endometrioid adenocarcinoma; the survival was not found to be correlated with GLUT-1 expression. Conclusion: GLUT-1 immunostaining may be useful in distinguishing hyperplasia without atypia from hyperplasia with atypia; GLUT-1 overexpression is a consistent feature of endometrioid adenocarcinoma. A correlation between GLUT-1 expression and tumor grade has been found, although other prognostic parameters and survival has no meaningful correlation.
引用
收藏
页码:141 / 147
页数:7
相关论文
共 50 条
  • [31] GLUT-1 as a predictor of worse prognosis in pancreatic adenocarcinoma: immunohistochemistry study showing the correlation between expression and survival
    Mar Achalandabaso Boira
    Marcello Di Martino
    Carlos Gordillo
    Magdalena Adrados
    Elena Martín-Pérez
    BMC Cancer, 20
  • [32] Clinical significance of COX-2, GLUT-1 and VEGF expressions in endometrial cancer tissues
    Ma, Xiaoping
    Hui, Yuzuo
    Lin, Li
    Wu, Yu
    Zhang, Xian
    Liu, Peishu
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2015, 31 (02) : 280 - 284
  • [33] Glut-1 expression in dysplastic and regenerative lesions of the colon
    Fogt, F
    Wellmann, A
    Urbanski, SJ
    Noffsinger, A
    Poremba, C
    Zimmerman, RL
    Alsaigh, N
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2001, 7 (06) : 615 - 619
  • [34] GLUT-1 expression and response to chemoradiotherapy in rectal cancer
    Brophy, Sarah
    Sheehan, Katherine M.
    McNamara, Deborah A.
    Deasy, Joseph
    Bouchier-Hayes, David J.
    Kay, Elaine W.
    INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (12) : 2778 - 2782
  • [35] Expression of glucose transporter 1 (Glut-1) in cell lines and clinical specimens from human prostate adenocarcinoma
    Effert, P
    Beniers, AJ
    Tamimi, Y
    Handt, S
    Jakse, G
    ANTICANCER RESEARCH, 2004, 24 (5A) : 3057 - 3063
  • [36] Expression and role of hScrib in endometrium, endometriosis, and endometrial adenocarcinoma
    Ouyang, Zhuo
    Chen, Minxiu
    Sun, Jinping
    Zhai, Jianjun
    MEDICINE, 2019, 98 (05) : 1
  • [37] Expression of HOXDIO Gene in Normal Endometrium and Endometrial Adenocarcinoma
    Janet Osborne
    Changzi Hu
    Colleen Hawley
    Lowell J. Underwood
    Timothy J. O’Brien
    Vicki V. Baker
    The Journal of the Society for Gynecologic Investigation: JSGI, 1998, 5 (5): : 277 - 280
  • [38] Expression of Glut-4 and Glut-1 transporters in rat diaphragm muscle
    Nie, X
    Hida, W
    Kikuchi, Y
    Kurosawa, H
    Tabata, M
    Kitamuro, T
    Adachi, T
    Ohno, I
    Shirato, K
    TISSUE & CELL, 2000, 32 (01): : 107 - 115
  • [39] Maspin expression, subcellular localization and clinicopathological correlation in endometrial hyperplasia and endometrial adenocarcinoma
    Blandamura, Stella
    Alessandrini, Lara
    Saccardi, Carlo
    Giacomelli, Luciano
    Fabris, Alberta
    Borghero, Angela
    Litta, Pietro
    HISTOLOGY AND HISTOPATHOLOGY, 2014, 29 (06) : 777 - 783
  • [40] Expression of Glut-1 is a prognostic marker for oral squamous cell carcinoma patients
    Eckert, A. W.
    Lautner, M. H. W.
    Taubert, H.
    Schubert, J.
    Bilkenroth, U.
    ONCOLOGY REPORTS, 2008, 20 (06) : 1381 - 1385